- $51.29m
- $33.38m
- $42.16m
- 47
- 57
- 81
- 65
Annual income statement for LENSAR, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30.5 | 26.4 | 34.5 | 35.4 | 42.2 |
Cost of Revenue | |||||
Gross Profit | 13.2 | 14.1 | 17.8 | 20 | 21.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 43.2 | 44.9 | 54.1 | 55.5 | 54.4 |
Operating Profit | -12.7 | -18.5 | -19.7 | -20.2 | -12.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.7 | -19.8 | -19.6 | -19.9 | -14.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.7 | -19.8 | -19.6 | -19.9 | -14.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.7 | -19.8 | -19.6 | -19.9 | -14.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.7 | -19.8 | -19.6 | -19.9 | -14.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.38 | -4.28 | -2.09 | -1.96 | -1.31 |
Dividends per Share |